Automated quantification of deep grey matter structures and white matter lesions using magnetic resonance imaging in relapsing remission multiple sclerosis

[1] Compston A(2002)Multiple sclerosis Lancet 359 1221-1231

[2] Coles A(2014)Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity Neurology 83 1022-1024

[3] Browne P(1989)The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course Brain 112 1419-1428

[4] Chandraratna D(2020)Systematic review of prediction models in relapsing remitting multiple sclerosis PLoS ONE 15 e0233575-936

[5] Angood C(2006)Sex ratio of multiple sclerosis in Canada: a longitudinal study Lancet Neurol 5 932-171

[6] Weinshenker BG(2004)The nature of multiple sclerosis Clin Neurol Neurosurg 106 159-10

[7] Bass B(2017)Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy Cell J 19 1-1452

[8] Rice GP(1983)Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444-323

[9] Brown FS(2019)The expanded disability status scale scoring in patients with multiple sclerosis Ideggyogy Sz 72 317-2471

[10] Glasmacher SA(2013)Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis J Neurol 260 2458-922

[1] Compston A(2002)Multiple sclerosis Lancet 359 1221-1231

[2] Coles A(2014)Atlas of multiple sclerosis 2013: A growing global problem with widespread inequity Neurology 83 1022-1024

[3] Browne P(1989)The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course Brain 112 1419-1428

[4] Chandraratna D(2020)Systematic review of prediction models in relapsing remitting multiple sclerosis PLoS ONE 15 e0233575-936

[5] Angood C(2006)Sex ratio of multiple sclerosis in Canada: a longitudinal study Lancet Neurol 5 932-171

[6] Weinshenker BG(2004)The nature of multiple sclerosis Clin Neurol Neurosurg 106 159-10

[7] Bass B(2017)Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy Cell J 19 1-1452

[8] Rice GP(1983)Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444-323

[9] Brown FS(2019)The expanded disability status scale scoring in patients with multiple sclerosis Ideggyogy Sz 72 317-2471

[10] Glasmacher SA(2013)Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis J Neurol 260 2458-922